コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 rculation via extracorporeal cardiopulmonary resuscitation).
2 echniques could potentially be used to guide resuscitation.
3 ssociated with pre-operative cardiopulmonary resuscitation.
4 cardiac arrest and mechanical trauma during resuscitation.
5 ce of the International Liaison Committee on Resuscitation.
6 atched whole blood during initial hemostatic resuscitation.
7 y favorable survival declines with prolonged resuscitation.
8 vasopressors, dialysis, and cardiopulmonary resuscitation.
9 with the International Liaison Committee on Resuscitation.
10 which represses rluD led to faster persister resuscitation.
11 ave undergone extracorporeal cardiopulmonary resuscitation.
12 st followed by 90 seconds of cardiopulmonary resuscitation.
13 siological parameters during cardiopulmonary resuscitation.
14 CA followed by 30 min cardiopulmonary bypass resuscitation.
15 rrhagic shock compared with crystalloid only resuscitation.
16 ing these measures a candidate to help guide resuscitation.
17 and with markers of quality cardiopulmonary resuscitation.
18 om blood could be obtained within 6 hours of resuscitation.
19 rticipating in an in-hospital cardiac arrest resuscitation.
20 ed cardiac arrest and died despite immediate resuscitation.
21 re hemorrhagic shock in the absence of fluid resuscitation.
22 ical services response time, and duration of resuscitation.
23 th poor perfusion) requiring cardiopulmonary resuscitation.
24 day mortality compared with crystalloid-only resuscitation.
25 2,3-d]pyrimidin-4(3H)-one (BPOET) stimulates resuscitation.
26 ce of the International Liaison Committee on Resuscitation.
27 58.0% receiving lay-rescuer cardiopulmonary resuscitation.
28 rt and 12.6% for those who received on-scene resuscitation.
29 t, product volumes transfused, and INR after resuscitation.
30 cle were administered during cardiopulmonary resuscitation.
31 68)) were administered within 5 min of fluid resuscitation.
32 rculation), compared with continued on-scene resuscitation.
33 ership and patient care during actual trauma resuscitations.
36 pocampus: sham, 0.4 +/- 0.2; cardiopulmonary resuscitation, 1.7 +/- 0.4; extracorporeal cardiopulmona
37 ren receiving extracorporeal cardiopulmonary resuscitation, 125 (85.0%) had a preexisting cardiac con
38 1.7 +/- 0.4; extracorporeal cardiopulmonary resuscitation, 2.3 +/- 0.2; extracorporeal cardiopulmona
39 2.5 +/- 0.4; extracorporeal cardiopulmonary resuscitation, 2.4 +/- 0.2; CO-E-CPR, 1.4 +/- 0.2; p < 0
40 xygenase-1 (sham, 1 +/- 0.1; cardiopulmonary resuscitation, 2.5 +/- 0.4; extracorporeal cardiopulmona
41 /- 169 pg/mL; extracorporeal cardiopulmonary resuscitation, 240 +/- 61 pg/mL; CO-E-CPR, 89 +/- 26 pg/
43 rs), received less bystander cardiopulmonary resuscitation (49.1% versus 54.9%), and had a lower prop
44 ly with hemodynamic-directed cardiopulmonary resuscitation (7/10) than depth-guided cardiopulmonary r
45 tion alone during the first 6 hours of fluid resuscitation after intensive care medicine (ICU) admiss
50 nt at 0.5 hours compared with extracorporeal resuscitation alone (regional cerebral oxygen saturation
52 patients had chosen to limit cardiopulmonary resuscitation and 214 (53.2%) had chosen to limit intuba
53 BLS (firefighters performing cardiopulmonary resuscitation and applying automated external defibrilla
55 t Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care focuses
56 ciation (AHA) Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care is based
57 0 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science
58 0 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science
59 0 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science
60 0 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science
61 h of cardiac arrest prior to cardiopulmonary resuscitation and is mediated by myocardial stunning res
62 re we determined whether the new hypothermic resuscitation and preservation solution HypoRP improves
63 ed by the International Liaison Committee on Resuscitation and resulted in the development of an inte
64 injury after extracorporeal cardiopulmonary resuscitation and the most common type was hypoxic-ische
66 iments about participating in cardiac arrest resuscitations and identify factors associated with conf
67 tracorporeal life support or cardiopulmonary resuscitation, and appearance of pathologic neurologic s
68 , appropriate routes of drug delivery during resuscitation, and consideration of when it is appropria
70 rom adult human control and CA patients post-resuscitation, and from male Sprague-Dawley rats at base
71 ervals for epinephrine administration during resuscitation, and the targets for oxygen and carbon dio
74 atients in the peripheral perfusion-targeted resuscitation arm had Sequential Organ Failure Assessmen
76 nin T), circulating SN levels declined after resuscitation, as the risk of a new arrhythmia waned.
78 ion strategy is superior to lactate-targeted resuscitation at 28 days was above 90% for all priors; t
79 to participate in in-hospital cardiac arrest resuscitation at a community, rural, or critical access
80 iatric patients who lose their pulse despite resuscitation attempts are at particularly high risk and
81 with HS, administration of synthetic RvD1 on resuscitation attenuated the multiple organ failure asso
83 ercent oxygen should not be used to initiate resuscitation because it is associated with excess morta
85 than or equal to 1 minute of cardiopulmonary resuscitation before venoarterial extracorporeal membran
86 ation, extension of advanced cardiopulmonary resuscitation beyond futility for organ preservation, mo
89 istory of cardiac arrest and cardiopulmonary resuscitation (CACPR) leads to inferior posttransplant o
91 echocardiography (TTE) during cardiac arrest resuscitation can enable the characterization of myocard
92 implementation of a QI package for neonatal resuscitation can reduce intrapartum-related mortality a
94 rming cardiac resuscitation centres for post-resuscitation care can substantially improve survival af
95 s about the use of emergency treatments like resuscitation care for in-hospital cardiac arrest (IHCA)
96 removal of foreign-body airway obstruction, resuscitation care for suspected opioid-associated emerg
97 ring transport, CPR before calling for help, resuscitation care for suspected opioid-associated emerg
99 stems with dedicated high-performing cardiac resuscitation centres for post-resuscitation care can su
100 l services arrival, and some cardiopulmonary resuscitation characteristics, but were similar in other
101 te provision of high-quality cardiopulmonary resuscitation combined with rapid defibrillation (as app
102 the basis of both recent interest within the resuscitation community and the amount of new evidence a
103 The benefit of intra-arrest transport during resuscitation compared with continued on-scene resuscita
104 when the International Liaison Committee on Resuscitation completes a literature review based on new
105 when the International Liaison Committee on Resuscitation completes a literature review based on new
108 ential to increase bystander cardiopulmonary resuscitation (CPR) and defibrillation in out-of-hospita
109 0 International Consensus on Cardiopulmonary Resuscitation (CPR) and Emergency Cardiovascular Care Sc
110 ly access to 9-1-1 and early cardiopulmonary resuscitation (CPR) are the first 2 links in the chain o
111 tent of staff involvement in cardiopulmonary resuscitation (CPR) efforts and its association with out
114 hen it is ethical to perform cardiopulmonary resuscitation (CPR) on patients during the COVID-19 pand
115 onse system, early bystander cardiopulmonary resuscitation (CPR) with an emphasis on chest compressio
116 ocol (transport with ongoing cardiopulmonary resuscitation [CPR] to the cardiac catheterization labor
117 n of cardiac arrest prior to cardiopulmonary resuscitation determined postresuscitation success rates
119 The median extracorporeal cardiopulmonary resuscitation duration was 3.2 days (interquartile range
122 he ability of extracorporeal cardiopulmonary resuscitation (ECPR) to modulate this decline is unknown
123 dvanced Life Support, Neonatal Life Support, Resuscitation Education Science, and Systems of Care Wri
124 ration of when it is appropriate to redirect resuscitation efforts after significant efforts have fai
127 witnessed status, bystander cardiopulmonary resuscitation, episode location, epinephrine dose, emerg
128 onger time from onset of the cardiopulmonary resuscitation event to extracorporeal membrane oxygenati
133 ses: termination of advanced cardiopulmonary resuscitation, extension of advanced cardiopulmonary res
134 nt of the International Liaison Committee on Resuscitation First Aid Task Force Consensus on Science
135 protein expression level are associated with resuscitation fluid administration magnitude and can be
136 ression was correlated with the administered resuscitation fluid better than the Acute Physiology and
137 s between children receiving cardiopulmonary resuscitation for bradycardia and poor perfusion and tho
139 Cardiogenic shock following cardiopulmonary resuscitation for sudden cardiac arrest is common, occur
141 e streptomycetes and mycobacteria, the rapid resuscitation from a dormant state requires the activiti
142 od pressure during the initial 6 hours after resuscitation from cardiac arrest was independently asso
143 itted to the intensive care unit (ICU) after resuscitation from cardiac arrest with nonshockable rhyt
146 efit of emergency coronary angiography after resuscitation from out-of-hospital cardiac arrest is unc
147 survivors without ST-segment elevation after resuscitation from out-of-hospital cardiac arrest were p
148 ts (21.3-67.7) in the early ECMO-facilitated resuscitation group (risk difference 36.2%, 3.7-59.2; po
151 egression determined the association between resuscitation groups and risk-adjusted 30-day mortality.
154 0 American Heart Association cardiopulmonary resuscitation guidelines was associated with only slight
155 0 American Heart Association cardiopulmonary resuscitation guidelines, 1.25% ([95% CI, 0.72%-1.78%] P
157 those who became positive (>0.3 units) after resuscitation had 3-times higher risk compared to those
159 rmal peripheral perfusion after septic shock resuscitation has been associated with organ dysfunction
161 and shockable rhythm during cardiopulmonary resuscitation, hospital level, and socioeconomic status.
162 my, artificial nutrition, or cardiopulmonary resuscitation); however, it was associated with a higher
163 f early norepinephrine administration during resuscitation; however, prospective data to support this
164 ry [TIMP-2]*[IGFBP7] following initial fluid resuscitation identify sepsis patients with differing ri
167 [TIMP-2]*[IGFBP7] before and after a 6-hour resuscitation in 688 patients with septic shock enrolled
168 tial oxygen concentrations for initiation of resuscitation in both preterm and term infants, use of e
169 Most children receiving cardiopulmonary resuscitation in ICUs had an initial rhythm of bradycard
170 s over face-mask ventilation during neonatal resuscitation in low-income countries, but whether the u
171 rdiac arrest, extracorporeal cardiopulmonary resuscitation in pediatric cardiac arrest, and pediatric
174 on) and required inotropic support and fluid resuscitation (including 23/29 [79%] who received mechan
176 essed to pulselessness after cardiopulmonary resuscitation initiation had lower intra-arrest hemodyna
177 ilatory or cardiogenic shock requiring fluid resuscitation, inotropic support, and in the most severe
178 chest compressions, shorten cardiopulmonary resuscitation interruptions, guide resuscitative procedu
182 ).Conclusions: Peripheral perfusion-targeted resuscitation may result in lower mortality and faster r
187 generation and improved postcardiopulmonary resuscitation myocardial function, neurologic outcomes,
188 either hemodynamic-directed cardiopulmonary resuscitation (n = 10; compression depth titrated to aor
189 >= 20 mm Hg) or depth-guided cardiopulmonary resuscitation (n = 12; depth 1/3 chest diameter, epineph
192 n Arterial Pressure After Cardiac Arrest and Resuscitation; NCT02698917) trials who were randomized t
193 ithin the International Liaison Committee on Resuscitation, new or revised treatment recommendations
194 that included extracorporeal cardiopulmonary resuscitation, no significant difference was seen in the
196 on identified extracorporeal cardiopulmonary resuscitation (odds ratio, 3.674; 95% CI, 1.425-9.473; o
199 uality improvement (QI) package for neonatal resuscitation on intrapartum-related mortality (intrapar
201 -Co), and limited-volume crystalloid (LV-Cr) resuscitation on the gut microbiota, and to evaluate its
202 ns of the International Liaison Committee on Resuscitation, only systematic reviews could result in a
203 randomly assigned to early ECMO-facilitated resuscitation or standard ACLS treatment on hospital arr
204 flumazenil, nonmechanical or cardiopulmonary resuscitation, or endotracheal intubation on the day of
206 aumatic adult EMS-treated OHCA data from the Resuscitation Outcomes Consortium (ROC) Cardiac Epidemio
207 thmic drug versus placebo in the ALPS trial (Resuscitation Outcomes Consortium Amiodarone, Lidocaine
208 ome in a secondary analysis of data from the Resuscitation Outcomes Consortium Amiodarone, Lidocaine,
211 trospective cohort study using data from the Resuscitation Outcomes Consortium Epistry at US sites.
212 r adjustment for patient characteristics and Resuscitation Outcomes Consortium site, a greater hypoth
213 le code leaders in regard to cardiopulmonary resuscitation outcomes in a real-world clinical setting.
216 an perceptions of in-hospital cardiac arrest resuscitation participation was developed after literatu
217 ize the use of epinephrine in cardiac arrest resuscitation, particularly the dose, timing, and mode o
218 One in four extracorporeal cardiopulmonary resuscitation patients achieved good neurologic outcome.
220 id response teams; measuring cardiopulmonary resuscitation performance, feedback devices, and debrief
221 the first 96 hours after burn, includes the resuscitation period and influences subsequent outcomes
222 al interspecies metabolic similarity in post-resuscitation plasma, our long duration CA rat model met
223 ventilation, prophylactic antibiotics after resuscitation, postresuscitation seizure prophylaxis and
224 We conducted a nationwide survey of hospital resuscitation practices in April of 2018, which were the
226 each 5 additional minutes of cardiopulmonary resuscitation prior to extracorporeal membrane oxygenati
227 iomyopathy and 66% underwent cardiopulmonary resuscitation prior to venoarterial extracorporeal membr
230 Patients were randomized to a step-by-step resuscitation protocol aimed at either normalizing capil
231 A perfusion specialist using a goal-directed resuscitation protocol managed all the animals during th
235 cardiac arrest recognition, cardiopulmonary resuscitation, public access defibrillation, mobile phon
238 otoxemic shock or saline (control) and fluid resuscitation (R) with or without O-GlcNAc stimulation (
240 n monoxide application during extracorporeal resuscitation reduces injury patterns in neuromonitoring
241 from our hospital's Get With The Guidelines-Resuscitation registry, a prospective hospital-based arc
242 nesthesia database, local data of the German Resuscitation Registry, and measurement logs of the depl
243 from SWEDEHEART, the Swedish Cardiopulmonary Resuscitation Registry, and the Swedish Pacemaker and Im
246 any signaling function associated with spore resuscitation requires the activity of additional yet to
247 rinatal death, admission to a neonatal unit, resuscitation requiring drugs and/or intubation, and an
248 nal defibrillators, and innovations to match resuscitation resources to victims in place and time.
250 rest transport vs 7.1% who received on-scene resuscitation (risk difference, 4.2% [95% CI, 3.5%-4.9%]
251 rest transport vs 8.5% who received on-scene resuscitation (risk difference, 4.6% [95% CI, 4.0%- 5.1%
252 on of the International Liaison Committee on Resuscitation's 2020 International Consensus on First Ai
253 with the International Liaison Committee on Resuscitation's continuous evidence review process, with
254 ly available, extracorporeal cardiopulmonary resuscitation should be considered for patients with car
257 2018, the International Liaison Committee on Resuscitation sponsored the COSCA initiative (Core Outco
258 scores were reduced compared with customary resuscitation strategies (hippocampus: sham, 0.4 +/- 0.2
261 ysfunction when compared with lactate-guided resuscitation strategy in patients with septic shock, bu
262 is unclear if a low- or high-volume IV fluid resuscitation strategy is better for patients with sever
263 ability that a peripheral perfusion-targeted resuscitation strategy is superior to lactate-targeted r
264 al showed that a peripheral perfusion-guided resuscitation strategy was associated with lower mortali
267 chanisms may be relevant for the early fluid resuscitation strategy.Objectives: To understand the rel
268 This document expands the cardiac arrest resuscitation system of care to include patients, caregi
270 rs from 6 International Liaison Committee on Resuscitation task forces have assessed, discussed, and
276 t of the patient with NVUGIB should focus on resuscitation, triage, and preparation for upper endosco
278 requent in nonextracorporeal cardiopulmonary resuscitation venoarterial extracorporeal membrane oxyge
279 real membrane oxygenation (ECMO)-facilitated resuscitation versus standard ACLS treatment in patients
280 vasopressor dosing intensity varies by fluid resuscitation volume; and 3) determine whether the effec
281 al rate after extracorporeal cardiopulmonary resuscitation was 29% (95% CI, 0.26-0.33%) and good neur
282 to hospital compared with continued on-scene resuscitation was associated with lower probability of s
285 up to 71%, withheld or withdrawn in 58%, and resuscitation was withheld in every fourth patient, but
286 stimulating Escherichia coli persister cell resuscitation, we identified that 2-{[2-(4-bromophenyl)-
290 e to 30 +/- 2 mm Hg, 90 minutes, followed by resuscitation) were treated with RvD1 (0.3 or 1 mug/kg i
293 fter three shocks, automated cardiopulmonary resuscitation with a Lund University Cardiac Arrest Syst
295 2.3 +/- 0.2; extracorporeal cardiopulmonary resuscitation with carbon monoxide application [CO-E-CPR
299 The findings support the notion that fluid resuscitation with unbuffered electrolyte solutions may
300 ss of the International Liaison Committee on Resuscitation, with updates published when the Internati